Professor Justin C Mason

Publications


Journals

  • Boyle JJ; Johns M; Kampfer T; Nguyen AT; Game L; Schaer DJ; Mason JC; Haskard DO. (6 Jan 2012). Activating transcription factor 1 directs mhem atheroprotective macrophages through coordinated iron handling and foam cell protection. Circ Res. 110:20-33. DOI.
  • Birdsey GM; Dryden NH; Shah AV; Hannah R; Hall MD; Haskard DO; Parsons M; Mason JC; et alZvelebil M; Gottgens B; Ridley AJ; Randi AM. (19 Jan 2012). The transcription factor Erg regulates expression of histone deacetylase 6 and multiple pathways involved in endothelial cell migration and angiogenesis. Blood. 119:894-903. DOI.
  • Yu Y; Crawley JTB; Mason JC; Lane DA. (Jul 2011). Protein kinase C isoforms in the divergent endothelial signalling exerted by thrombin- and activated protein c-dependent activation of PAR-1. J THROMB HAEMOST. 9:239-239.
  • Nazareth R; Mason JC. (Sep 2011). Takayasu arteritis: severe consequences of delayed diagnosis. QJM-INT J MED. 104:797-800. DOI.
  • Boyle JJ; Johns M; Lo J; Chiodini A; Ambrose N; Evans PC; Mason JC; Haskard DO. (Nov 2011). Heme induces heme oxygenase 1 via Nrf2: role in the homeostatic macrophage response to intraplaque hemorrhage. Arterioscler Thromb Vasc Biol. 31:2685-2691. DOI.
  • Mason JC; Ahmad SR; Lidington EA; Ohta R; Okada N; Davies KA; Haskard DO. (Apr 2003). THE COMPLEMENT REGULATORY PROTEIN DECAY-ACCELERATING FACTOR (DAF) IS UPREGULATED ON MURINE VASCULAR ENDOTHELIUM IN VITRO AND DURING GLOMERULONEPHRITIS IN VIVO. RHEUMATOLOGY. 42:124-124.
  • Philippidis P; Evans BJ; Mason JC; Taylor KM; Haskard DO; Landis C. (Apr 2004). THE HAEMOGLOBIN SCAVENGER RECEPTOR CD163 MEDIATES MACROPHAGE INTERLEUKIN-10 AND HAEM OXYGENASE-1 SYNTHESIS: AN INDUCIBLE CYTOPROTECTIVE PATHWAY AGAINST HAEMOGLOBIN-MEDIATED OXIDATIVE VASCULAR INJURY. RHEUMATOLOGY. 43:8-8.
  • Hepburn AL; Mason JC; Davies KA. (Apr 2002). EXPRESSION OF Fc gamma RII AND ICAM-1 IS REDUCED ON PERIPHERAL BLOOD MONOCYTES FROM PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS. RHEUMATOLOGY. 41:30-30.
  • Hepburn AL; Mason JC; Wang S; Walport MJ; Davies KA. (Apr 2004). A ROLE FOR BOTH COMPLEMENT AND Fc gamma RECEPTORS IN THE TRANSFER OF SOLUBLE IMMUNE COMPLEXES FROM ERYTHROCYTES TO MONOCYTE-DERIVED MACROPHAGES IN A DYNAMIC IN VITRO HUMAN MODEL. RHEUMATOLOGY. 43:28-28.
  • Andrews J; Malik IS; Davies K; Haskard DO; Mason JC. (Apr 2002). EVALUATION OF FDG-PET AND MR IMAGING IN TAKAYASU'S ARTERITIS. RHEUMATOLOGY. 41:19-19.
  • Florey O; Mason JC; Haskard DO. (Apr 2004). LIGATION OF LEUKOCYTE FC gamma RII (CD32) BY AN ANTI-ENDOTHELIAL CELL (EC) ANTIBODY SYNERGISES WITH G-PROTEIN COUPLED RECEPTOR SIGNALLING TO AMPLIFY LEUKOCYTE ADHESION TO CYTOKINE-ACTIVATED UNDER PHYSIOLOGICAL FLOW. RHEUMATOLOGY. 43:30-31.
  • Bussolati B; Ahmed A; Landis RC; Di Carlo F; Pemberton H; Haskard DO; Mason JC. (Apr 2004). BIFUNCTIONAL ROLE FOR VEGF-INDUCED HEME OXYGENASE-1 IN VIVO: INDUCTION OF ANGIOGENESIS AND INHIBITION OF LEUKOCYTIC INFILTRATION. RHEUMATOLOGY. 43:30-30.
  • Mason JC; Lidington EA; Mankoff R; Kinderlerer AR; Ohba M; Haskard DO. (Apr 2004). VEGF-INDUCED CYTOPROTECTION OF VASCULAR ENDOTHELIUM IS DIFFERENTIALLY REGULATED BY CYCLOSPORIN A AND RAPAMYCIN. RHEUMATOLOGY. 43:30-30.
  • Nadra I; Mason JC; McCarthy GM; Landis C; Haskard DO. (Apr 2004). BASIC CALCIUM PHOSPHATE CRYSTAL-INDUCED SECRETION OF PRO-INFLAMMATORY CYTOKINES BY HUMAN MONOCYTE/MACROPHAGES LEADING TO ENDOTHELIAL ACTIVATION MEDIATED THROUGH PROTEIN KINASE C alpha AND epsilon, MEK-1/2 MAP KINASE AND NF kappa B INTRACELLULAR SIGNALING PATHWAYS. RHEUMATOLOGY. 43:55-55.
  • Hepburn AL; Mason JC; Walport MJ; Davies KA. (Apr 2003). Fc gamma RECEPTORS II (CD32) AND III (CD16) MEDIATE ADHESION OF IMMUNE COMPLEX BEARING ERYTHROCYTES TO MONONUCLEAR PHAGOCYTES UNDER PHYSIOLOGICAL FLOW CONDITIONS IN VITRO. RHEUMATOLOGY. 42:73-73.
  • Ng WF; Cohen P; Hamdulay S; Hepburn A; Carpani M; Mason JC. (Apr 2004). EOSINOPHILIC GASTROENTERITIS AND RHEUMATOID ARTHRITIS. RHEUMATOLOGY. 43:117-117.
  • Mason JC. (Jul 2005). FDG-PET SCANNING. RHEUMATOLOGY. 44:10-10. DOI.
  • Hepburn AL; Davies KA; Mason JC. (Apr 2003). INCREASED EXPRESSION OF DECAY-ACCELERATING FACTOR BUT NOT CD59 ON PERIPHERAL BLOOD LEUCOCYTES FROM PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND RHEUMATOID ARTHRITIS. RHEUMATOLOGY. 42:73-74.
  • Kinderlerer AR; Mankoff R; Maxwell PH; Haskard DO; Mason JC. (Apr 2004). UPREGULATION OF MEMBRANE-BOUND COMPLEMENT REGULATORY PROTEINS BY ATORVASTATIN PROTECTS VASCULAR ENDOTHELIUM AGAINST COMPLEMENT-MEDIATED INJURY DURING HYPOXIA-REOXYGENATION. RHEUMATOLOGY. 43:8-8.
  • Lidington EA; Rao RM; Marelli-Berg F; Jat P; Haskard DO; Mason JC. (Apr 2001). Isolation and characterisation of conditionally immortal growth factor responsive cardiac endothelial cells (EC) from H-2K(b)-tsA58 transgenic mice. RHEUMATOLOGY. 40:8-8.
  • Yagnik DR; Mason JC; Landis C; Haskard DO. (Apr 2003). DIFFERENTIATION OF MONOCYTES TO MACROPHAGES ALTERS CYTOKINE RELEASE IN RESPONSE TO MONOSODIUM URATE (MSU) CRYSTALS: ROLE OF MACROPHAGE TGF-BETA 1 IN THE RESOLUTION OF ACUTE GOUT. RHEUMATOLOGY. 42:4-5.
  • Mason JC; Ahmed Z; Lidington EA; Mankoff R; Ahmad SR; Randi A; Haskard DO. (Apr 2002). STATIN-INDUCED EXPRESSION OF COMPLEMENT INHIBITORY PROTEINS PROTECTS VASCULAR ENDOTHELIUM AGAINST COMPLEMENT-MEDIATED INJURY. RHEUMATOLOGY. 41:8-8.
  • Cuhlmann S; Van der Heiden K; Saliba D; Tremoleda JL; Khalil M; Zakkar M; Chaudhury H; Luong LEA; et alMason JC; Udalova I; Gsell W; Jones H; Haskard DO; Krams R; Evans PC. (15 Apr 2011). Disturbed blood flow induces RelA expression via c-Jun N-terminal kinase 1: a novel mode of NF-κB regulation that promotes arterial inflammation. Circ Res. 108:950-959. DOI.
  • Zakkar M; Luong LEA; Chaudhury H; Ruud O; Punjabi PP; Anderson JR; Mullholand JW; Clements AT; et alKrams R; Foin N; Athanasiou T; Leen EL; Mason JC; Haskard DO; Evans PC. (8 Feb 2011). Dexamethasone arterializes venous endothelial cells by inducing mitogen-activated protein kinase phosphatase-1: a novel antiinflammatory treatment for vein grafts?. Circulation. 123:524-532. DOI.
  • Lamare F; Hinz R; Gaemperli O; Pugliese F; Mason JC; Spinks T; Camici PG; Rimoldi OE. (Jan 2011). Detection and quantification of large-vessel inflammation with 11C-(R)-PK11195 PET/CT. J Nucl Med. 52:33-39. DOI.
  • Sperone A; Dryden NH; Birdsey GM; Madden L; Johns M; Evans PC; Mason JC; Haskard DO; et alBoyle JJ; Paleolog EM; Randi AM. (Jan 2011). The transcription factor Erg inhibits vascular inflammation by repressing NF-kappaB activation and proinflammatory gene expression in endothelial cells. Arterioscler Thromb Vasc Biol. 31:142-150. DOI.
  • Nazareth R; Mason JC. (Sep 2011). Takayasu arteritis: severe consequences of delayed diagnosis. QJM. 104:797-800. DOI.
  • Bai X; Margariti A; Hu Y; Sato Y; Zeng L; Ivetic A; Habi O; Mason JC; et alWang X; Xu Q. (Dec 2010). Protein kinase C{delta} deficiency accelerates neointimal lesions of mouse injured artery involving delayed reendothelialization and vasohibin-1 accumulation. Arterioscler Thromb Vasc Biol. 30:2467-2474. DOI.
  • Hepburn AL; Narat S; Mason JC. (Dec 2010). The management of peripheral blood cytopenias in systemic lupus erythematosus. Rheumatology (Oxford). 49:2243-2254. DOI.
  • Pugliese F; Gaemperli O; Kinderlerer AR; Lamare F; Shalhoub J; Davies AH; Rimoldi OE; Mason JC; et alCamici PG. (17 Aug 2010). Imaging of vascular inflammation with [11C]-PK11195 and positron emission tomography/computed tomography angiography. J Am Coll Cardiol. 56:653-661. DOI.
  • Mason JC. (Jul 2010). Takayasu arteritis--advances in diagnosis and management. Nat Rev Rheumatol. 6:406-415. DOI.
  • Keenan NG; Mason JC; Pennell DJ. (22 Feb 2010). Reply to letter AR-09-1666 concerning our article: "Integrated cardiac and vascular assessment in takayasu arteritis by cardiovascular magnetic resonance". Arthritis Rheum. DOI.
  • Gaemperli O; Boyle JJ; Rimoldi OE; Mason JC; Camici PG. (Jun 2010). Molecular imaging of vascular inflammation. Eur J Nucl Med Mol Imaging. 37:1236. DOI.
  • Zampetaki A; Zeng LF; Margariti A; Xiao QZ; Li HL; Zhang ZY; Pepe AE; Wang G; et alHabi O; deFalco E; Cockerill G; Mason JC; Hu YH; Xu QB. (5 Jan 2010). Histone Deacetylase 3 Is Critical in Endothelial Survival and Atherosclerosis Development in Response to Disturbed Flow. CIRCULATION. 121:132-142. DOI.
  • Hamdulay SS; Wang B; Birdsey GM; Ali F; Dumont O; Evans PC; Haskard DO; Wheeler-Jones CP; et alMason JC. (15 Apr 2010). Celecoxib activates PI-3K/Akt and mitochondrial redox signaling to enhance heme oxygenase-1-mediated anti-inflammatory activity in vascular endothelium. Free Radic Biol Med. 48:1013-1023. DOI.
  • Chaudhury H; Zakkar M; Boyle J; Cuhlmann S; van der Heiden K; Luong LEA; Davis J; Platt A; et alMason JC; Krams R; Haskard DO; Clark AR; Evans PC. (Mar 2010). c-Jun N-terminal kinase primes endothelial cells at atheroprone sites for apoptosis. Arterioscler Thromb Vasc Biol. 30:546-553. DOI.
  • Keenan NG; Mason JC; Maceira A; Assomull R; O'Hanlon R; Chan C; Roughton M; Andrews J; et alGatehouse PD; Firmin DN; Pennell DJ. (Nov 2009). Integrated Cardiac and Vascular Assessment in Takayasu Arteritis by Cardiovascular Magnetic Resonance. ARTHRITIS RHEUM. 60:3501-3509. DOI.
  • Ali F; Ali NS; Bauer A; Boyle JJ; Hamdulay SS; Haskard DO; Randi AM; Mason JC. (1 Mar 2010). PPARdelta and PGC1alpha act cooperatively to induce haem oxygenase-1 and enhance vascular endothelial cell resistance to stress. Cardiovasc Res. 85:701-710. DOI.
  • Leung VWY; Yun S; Botto M; Mason JC; Malik TH; Song WC; Paixao-Cavalcante D; Pickering MC; et alBoyle JJ; Haskard DO. (Oct 2009). Decay-Accelerating Factor Suppresses Complement C3 Activation and Retards Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice. AM J PATHOL. 175:1757-1767. DOI.
  • Hamdulay SS; Mason JC. (15 Sep 2009). Disease-modifying anti-rheumatic drugs: do they reduce cardiac complications of RA?. HEART. 95:1471-1472. DOI.
  • Zakkar M; Van der Heiden K; Luong LEA; Chaudhury H; Cuhlmann S; Hamdulay SS; Krams R; Edirisinghe I; et alRahman I; Carlsen H; Haskard DO; Mason JC; Evans PC. (Nov 2009). Activation of Nrf2 in endothelial cells protects arteries from exhibiting a proinflammatory state. Arterioscler Thromb Vasc Biol. 29:1851-1857. DOI.
  • Recio-Mayoral A; Mason JC; Kaski JC; Rubens MB; Harari OA; Camici PG. (Aug 2009). Chronic inflammation and coronary microvascular dysfunction in patients without risk factors for coronary artery disease. Eur Heart J. 30:1837-1843. DOI.
  • Ali F; Zakkar M; Karu K; Lidington EA; Hamdulay SS; Boyle JJ; Zloh M; Bauer A; et alHaskard DO; Evans PC; Mason JC. (10 Jul 2009). Induction of the cytoprotective enzyme heme oxygenase-1 by statins is enhanced in vascular endothelium exposed to laminar shear stress and impaired by disturbed flow. J Biol Chem. 284:18882-18892. DOI.
  • Kinderlerer AR; Gregoire IP; Hamdulay SS; Ali F; Steinberg R; Silva G; Ali N; Wang BF; et alHaskard DO; Soares MP; Mason JC. (12 Feb 2009). Heme oxygenase-1 expression enhances vascular endothelial resistance to complement-mediated injury through induction of decay-accelerating factor: a role for increased bilirubin and ferritin. BLOOD. 113:1598-1607. DOI.
  • Zakkar M; Chaudhury H; Sandvik G; Enesa K; Luong LA; Cuhlmann S; Mason JC; Krams R; et alClark AR; Haskard DO; Evans PC. (26 Sep 2008). Increased endothelial mitogen-activated protein kinase phosphatase-1 expression suppresses proinflammatory activation at sites that are resistant to atherosclerosis. CIRC RES. 103:726-732. DOI.
  • Peake STC; Mason JC; Mittal T; Amrani M; Mohiaddin R; Bell A; Grocott-Mason R; Dubrey SW. (16 Aug 2008). Growing pains - and a heart attack. LANCET. 372:600-600.
  • Haskard DO; Boyle JJ; Mason JC. (Oct 2008). The role of complement in atherosclerosis. Curr Opin Lipidol. 19:478-482. DOI.
  • Al Farrant M; Mason JC; Wong NACS; Longman RJ. (7 Jul 2008). Takayasu's arteritis following Crohn's disease in a young woman: Any evidence for a common pathogenesis?. WORLD J GASTROENTERO. 14:4087-4090. DOI.
  • Su PQ; Li R; Liu SL; Zhou Y; Wang XG; Patil N; Mow CS; Mason JC; et alHuang DS; Wang YM. (Jun 2008). Age at onset-dependent presentations of premature hip osteoarthritis, avascular necrosis of the femoral head, or Legg-Calve-Perthes disease in a single family, consequent upon a p.Gly1170Ser mutation of COL2A1. ARTHRITIS RHEUM. 58:1701-1706. DOI.
  • Kinderlerer AR; Ali F; Johns M; Lidington EA; Leung V; Boyle JJ; Hamdulay SS; Evans PC; et alHaskard DO; Mason JC. (23 May 2008). KLF2-dependent, shear stress-induced expression of CD59 - A novel cytoprotective mechanism against complement-mediated injury in the vasculature. J BIOL CHEM. 283:14636-14644. DOI.
  • Enesa K; Zakkar M; Chaudhury H; Luong LA; Rawlinson L; Mason JC; Haskard DO; Dean JLE; et alEvans PC. (14 Mar 2008). NF-kappa B suppression by the deubiquitinating enzyme Cezanne - A novel negative feedback loop in pro-inflammatory signaling. J BIOL CHEM. 283:7036-7045. DOI.
  • Birdsey GM; Dryden NH; Amsellem V; Gebhardt F; Sahnan K; Haskard DO; Dejana E; Mason JC; et alRandi AM. (1 Apr 2008). Transcription factor Erg regulates angiogenesis and endothelial apoptosis through VE-cadherin. Blood. 111:3498-3506. DOI.
  • Ali F; Hamdulay SS; Kinderlerer AR; Boyle JJ; Lidington EA; Yamaguchi T; Soares MP; Haskard DO; et alRandi AM; Mason JC. (Dec 2007). Statin-mediated cytoprotection of human vascular endothelial cells: a role for Kruppel-like factor 2-dependent induction of heme oxygenase-1. J THROMB HAEMOST. 5:2537-2546.
  • Steinberg R; Harari OA; Lidington EA; Boyle JJ; Nohadani M; Samarel AM; Ohba M; Haskard DO; et alMason JC. (2 Nov 2007). A protein kinase C epsilon-anti-apoptotic kinase signaling complex protects human vascular endothelial cells against apoptosis through induction of Bcl-2. J BIOL CHEM. 282:32288-32297. DOI.
  • Hepburn AL; Lampert IA; Boyle JJ; Horncastle D; Ng WF; Layton M; Vyse TJ; Botto M; et alMason JC. (Aug 2007). In vivo evidence for apoptosis in the bone marrow in systemic lupus erythematosus. ANN RHEUM DIS. 66:1106-1109. DOI.
  • Mason JC. (May 2007). The role of statins in vascular protection. Clin Adv Hematol Oncol. 5:352-354.
  • Partridge J; Carlsen H; Enesa K; Chaudhury H; Zakkar M; Luong L; Kinderlerer A; Johns M; et alBlomhoff R; Mason JC; Haskard DO; Evans PC. (Nov 2007). Laminar shear stress acts as a switch to regulate divergent functions of NF-kappaB in endothelial cells. FASEB J. 21:3553-3561. DOI.
  • Greenwood J; Mason JC. (Feb 2007). Statins and the vascular endothelial inflammatory response. TRENDS IMMUNOL. 28:88-98.
  • Florey OJ; Johns M; Esho OO; Mason JC; Haskard DO. (1 May 2007). Antiendothelial cell antibodies mediate enhanced leukocyte adhesion to cytokine-activated endothelial cells through a novel mechanism requiring cooperation between Fc{gamma}RIIa and CXCR1/2. Blood. 109:3881-3889. DOI.
  • Andrews J; Mason JC. (Jan 2007). Takayasu's arteritis--recent advances in imaging offer promise. Rheumatology (Oxford). 46:6-15. DOI.
  • Hepburn AL; Mason JC; Wang S; Shepherd CJ; Florey O; Haskard DO; Davies KA. (Oct 2006). Both Fcgamma and complement receptors mediate transfer of immune complexes from erythrocytes to human macrophages under physiological flow conditions in vitro. Clin Exp Immunol. 146:133-145. DOI.
  • Bussolati B; Mason JC. (Jul 2006). Dual role of VEGF-induced heme-oxygenase-1 in angiogenesis. ANTIOXID REDOX SIGN. 8:1153-1163.
  • Kinderlerer AR; Steinberg R; Johns M; Harten SK; Lidington EA; Haskard DO; Maxwell PH; Mason JC. (2006). Statin-induced expression of CD59 on vascular endothelium in hypoxia: a potential mechanism for the anti-inflammatory actions of statins in rheumatoid arthritis. Arthritis Res Ther. 8:R130. DOI.
  • Ng WF; Fantin F; Ng C; Dockery F; Schiff R; Davies KA; Rajkumar C; Mason JC. (Jun 2006). Takayasu's arteritis: a cause of prolonged arterial stiffness. Rheumatology (Oxford). 45:741-745. DOI.
  • Hamdulay SS; Cook HT; Strickland N; Davies KA; Mason JC. (Apr 2007). Peritoneal mesothelioma: an unusual cause of an acute phase response presenting to the rheumatologist. Clin Rheumatol. 26:584-586. DOI.
  • Day JR; Taylor KM; Lidington EA; Mason JC; Haskard DO; Randi AM; Landis RC. (Jan 2006). Aprotinin inhibits proinflammatory activation of endothelial cells by thrombin through the protease-activated receptor 1. J Thorac Cardiovasc Surg. 131:21-27. DOI.
  • Ng WF; Cohen P; Hepburn A; Hamdulay S; Carpani M; Mason JC. (Dec 2005). A case of eosinophilic enteritis and rheumatoid arthritis. RHEUMATOLOGY. 44:1585-1586. DOI.
  • Lidington EA; Steinberg R; Kinderlerer AR; Landis RC; Ohba M; Samarel A; Haskard DO; Mason JC. (Dec 2005). A role for proteinase-activated receptor 2 and PKC-epsilon in thrombin-mediated induction of decay-accelerating factor on human endothelial cells. Am J Physiol Cell Physiol. 289:C1437-C1447. DOI.
  • Huang MT; Mason JC; Birdsey GM; Amsellem V; Gerwin N; Haskard DO; Ridley AJ; Randi AM. (1 Sep 2005). Endothelial intercellular adhesion molecule (ICAM)-2 regulates angiogenesis. Blood. 106:1636-1643. DOI.
  • Singh RJR; Mason JC; Lidington EA; Edwards DR; Nuttall RK; Khokha R; Knauper V; Murphy G; et alGavrilovic J. (1 Jul 2005). Cytokine stimulated vascular cell adhesion molecule-1 (VCAM-1) ectodomain release is regulated by TIMP-3. CARDIOVASC RES. 67:39-49. DOI.
  • Nadra I; Mason JC; Philippidis P; Florey O; Smythe CD; McCarthy GM; Landis RC; Haskard DO. (24 Jun 2005). Proinflammatory activation of macrophages by basic calcium phosphate crystals via protein kinase C and MAP kinase pathways: a vicious cycle of inflammation and arterial calcification?. Circ Res. 96:1248-1256. DOI.
  • Mason JC. (Jan 2005). The statins--therapeutic diversity in renal disease?. Curr Opin Nephrol Hypertens. 14:17-24.
  • Mason JC; Steinberg R; Lidington EA; Kinderlerer AR; Ohba M; Haskard DO. (1 Oct 2004). Decay-accelerating factor induction on vascular endothelium by vascular endothelial growth factor (VEGF) is mediated via a VEGF receptor-2 (VEGF-R2)- and protein kinase C-alpha/epsilon (PKCalpha/epsilon)-dependent cytoprotective signaling pathway and is inhibited by cyclosporin A. J Biol Chem. 279:41611-41618. DOI.
  • Andrews J; Al-Nahhas A; Pennell DJ; Hossain MS; Davies KA; Haskard DO; Mason JC. (Aug 2004). Non-invasive imaging in the diagnosis and management of Takayasu's arteritis. Ann Rheum Dis. 63:995-1000. DOI.
  • Yagnik DR; Evans BJ; Florey O; Mason JC; Landis RC; Haskard DO. (Jul 2004). Macrophage release of transforming growth factor beta1 during resolution of monosodium urate monohydrate crystal-induced inflammation. Arthritis Rheum. 50:2273-2280. DOI.
  • Hepburn AL; Mason JC; Davies KA. (May 2004). Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis. Rheumatology (Oxford). 43:547-554. DOI.
  • Webb M; Chambers A; AL-Nahhas A; Mason JC; Maudlin L; Rahman L; Frank J. (May 2004). The role of 18F-FDG PET in characterising disease activity in Takayasu arteritis. Eur J Nucl Med Mol Imaging. 31:627-634. DOI.
  • Bussolati B; Ahmed A; Pemberton H; Landis RC; Di Carlo F; Haskard DO; Mason JC. (1 Feb 2004). Bifunctional role for VEGF-induced heme oxygenase-1 in vivo: induction of angiogenesis and inhibition of leukocytic infiltration. Blood. 103:761-766. DOI.
  • Philippidis P; Mason JC; Evans BJ; Nadra I; Taylor KM; Haskard DO; Landis RC. (9 Jan 2004). Hemoglobin scavenger receptor CD163 mediates interleukin-10 release and heme oxygenase-1 synthesis: antiinflammatory monocyte-macrophage responses in vitro, in resolving skin blisters in vivo, and after cardiopulmonary bypass surgery. Circ Res. 94:119-126. DOI.
  • Ahmad SR; Lidington EA; Ohta R; Okada N; Robson MG; Davies KA; Leitges M; Harris CL; et alHaskard DO; Mason JC. (Oct 2003). Decay-accelerating factor induction by tumour necrosis factor-alpha, through a phosphatidylinositol-3 kinase and protein kinase C-dependent pathway, protects murine vascular endothelial cells against complement deposition. Immunology. 110:258-268.
  • Mason JC. (Sep 2003). Statins and their role in vascular protection. Clin Sci (Lond). 105:251-266. DOI.
  • Landis RC; Yagnik DR; Florey O; Philippidis P; Emons V; Mason JC; Haskard DO. (Nov 2002). Safe disposal of inflammatory monosodium urate monohydrate crystals by differentiated macrophages. Arthritis Rheum. 46:3026-3033. DOI.
  • Mason JC; Ahmed Z; Mankoff R; Lidington EA; Ahmad S; Bhatia V; Kinderlerer A; Randi AM; et alHaskard DO. (18 Oct 2002). Statin-induced expression of decay-accelerating factor protects vascular endothelium against complement-mediated injury. Circ Res. 91:696-703.
  • Mason JC; Lidington EA; Ahmad SR; Haskard DO. (Mar 2002). bFGF and VEGF synergistically enhance endothelial cytoprotection via decay-accelerating factor induction. Am J Physiol Cell Physiol. 282:C578-C587. DOI.
  • Lidington EA; Rao RM; Marelli-Berg FM; Jat PS; Haskard DO; Mason JC. (Jan 2002). Conditional immortalization of growth factor-responsive cardiac endothelial cells from H-2K(b)-tsA58 mice. Am J Physiol Cell Physiol. 282:C67-C74.
  • Bussolati B; Dunk C; Grohman M; Kontos CD; Mason J; Ahmed A. (Sep 2001). Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide. Am J Pathol. 159:993-1008. DOI.
  • Asimakopoulos G; Lidington EA; Mason J; Haskard DO; Taylor KM; Landis RC. (Jul 2001). Effect of aprotinin on endothelial cell activation. J Thorac Cardiovasc Surg. 122:123-128. DOI.
  • Mason JC; Lidington EA; Yarwood H; Lublin DM; Haskard DO. (Jan 2001). Induction of endothelial cell decay-accelerating factor by vascular endothelial growth factor: a mechanism for cytoprotection against complement-mediated injury during inflammatory angiogenesis. Arthritis Rheum. 44:138-150. DOI.
  • Lidington EA; Haskard DO; Mason JC. (15 Oct 2000). Induction of decay-accelerating factor by thrombin through a protease-activated receptor 1 and protein kinase C-dependent pathway protects vascular endothelial cells from complement-mediated injury. Blood. 96:2784-2792.
  • Lidington EA; Haskard DO; Mason JC. (15 Oct 2000). Induction of decay-accelerating factor by thrombin through a protease-activated receptor 1 and protein kinase C-dependent pathway protects vascular endothelial cells from complement-mediated injury. BLOOD. 96:2684-2692.
  • Asimakopoulos G; Thompson R; Nourshargh S; Lidington EA; Mason JC; Ratnatunga CP; Haskard DO; Taylor KM; et alLandis RC. (Aug 2000). An anti-inflammatory property of aprotinin detected at the level of leukocyte extravasation. J Thorac Cardiovasc Surg. 120:361-369. DOI.
  • Yarwood H; Mason JC; Mahiouz D; Sugars K; Haskard DO. (Aug 2000). Resting and activated T cells induce expression of E-selectin and VCAM-1 by vascular endothelial cells through a contact-dependent but CD40 ligand-independent mechanism. J Leukoc Biol. 68:233-242.
  • Pickering MC; Barkham T; Mason JC; Shaunak S; Davies KA. (Feb 2000). Bilateral gluteal abscesses as a unique manifestation of Fusobacterium septicaemia. RHEUMATOLOGY. 39:224-225.
  • Thornton M; Barkley L; Mason JC; Shaunak S. (Oct 1999). Anti-Kaposi's sarcoma and antiangiogenic activities of sulfated dextrins. Antimicrob Agents Chemother. 43:2528-2533.
  • Mason JC; Yarwood H; Sugars K; Morgan BP; Davies KA; Haskard DO. (1 Sep 1999). Induction of decay-accelerating factor by cytokines or the membrane-attack complex protects vascular endothelial cells against complement deposition. Blood. 94:1673-1682.
  • Ussov WY; Peters AM; Chapman PT; Ttofi A; Mason JC; Haskard DO; Hughes JM. (May 1999). Pulmonary granulocyte kinetics in relation to endothelial and granulocyte activation. Clin Sci (Lond). 96:525-531.
  • Mason JC; Yarwood H; Sugars K; Haskard DO. (Oct 1997). Human umbilical vein and dermal microvascular endothelial cells show heterogeneity in response to PKC activation. Am J Physiol. 273:C1233-C1240.
  • AlShahi R; Mason JC; Rao R; Hurd C; Thompson EM; Haskard DO; Davies KA. (Jul 1997). Systemic lupus erythematosus, thrombocytopenia, microangiopathic haemolytic anaemia and anti-CD36 antibodies. BRIT J RHEUMATOL. 36:794-798.
  • Mason JC; Yarwood H; Tárnok A; Sugars K; Harrison AA; Robinson PJ; Haskard DO. (15 Jul 1996). Human Thy-1 is cytokine-inducible on vascular endothelial cells and is a signaling molecule regulated by protein kinase C. J Immunol. 157:874-883.
  • Davies KA; Cope AP; Schofield JB; Chu CQ; Mason JC; Krausz T; Smith P; Denman AM; et alWalport MJ. (Jan 1995). A rare mediastinal tumour presenting with systemic effects due to IL-6 and tumour necrosis factor (TNF) production. Clin Exp Immunol. 99:117-123.
  • Mason JC; Cowie MR; Davies KA; Schofield JB; Cambridge J; Jackson J; So A; Allard SA; et alWalport MJ. (Aug 1994). Familial polyarteritis nodosa. Arthritis Rheum. 37:1249-1253.
  • MASON JC; HASKARD DO. (Feb 1994). INCREASED LEVELS OF INTERCELLULAR-ADHESION MOLECULE-1 IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS - COMMENT ON THE ARTICLE BY MASON ET-AL - REPLY. ARTHRITIS RHEUM. 37:300-301.
  • Wellicome SM; Kapahi P; Mason JC; Lebranchu Y; Yarwood H; Haskard DO. (Jun 1993). Detection of a circulating form of vascular cell adhesion molecule-1: raised levels in rheumatoid arthritis and systemic lupus erythematosus. Clin Exp Immunol. 92:412-418.
  • Mason JC; Kapahi P; Haskard DO. (Apr 1993). Detection of increased levels of circulating intercellular adhesion molecule 1 in some patients with rheumatoid arthritis but not in patients with systemic lupus erythematosus. Lack of correlation with levels of circulating vascular cell adhesion molecule 1. Arthritis Rheum. 36:519-527.
  • De Wit D; Mulla R; Cowie MR; Mason JC; Davies KA. (Apr 1993). Vertebral osteomyelitis due to Staphylococcus epidermidis. Br J Rheumatol. 32:339-341.
  • Mason JC; Dollery CT; So A; Cohen J; Bloom SR; Bulpitt C; Russell-Jones R; Oakley CM. (1 Aug 1992). An infected prosthetic hip. Is there a role for prophylactic antibiotics?. BMJ. 305:300-302.
  • MASON JC; DOLLERY CT; SO A; COHEN J; BLOOM SR; BULPITT C; RUSSELLJONES R; OAKLEY CM. (1 Aug 1992). HAMMERSMITH STAFF ROUNDS - AN INFECTED PROSTHETIC HIP. BRIT MED J. 305:300-302.
  • MASON JC; WALPORT MJ. (11 Jul 1992). GIANT-CELL ARTERITIS - PROBABLY UNDERDIAGNOSED AND OVERTREATED. BRIT MED J. 305:68-69.
  • MASON JC; BRUCE RMCS; AZADIAN BS; WALL RA. (24 Jul 1986). HTLV-III ANTIBODY IN EAST-AFRICA. NEW ENGL J MED. 315:259-260.

Books

  • Hewins P. Mason JC (ed); Pusey CD (ed). The Kidney in Systemic Autoimmune Diseases. 1, Handbook of Systemic Autoimmune Diseases:1-407. Elsevier, The Netherlands (2008).

Chapters in books

  • Mason JC; Ali F. Atherosclerosis. In Atherosclerosis. Molecular and Cellular Mechanisms. 301-323. George SJ (ed); Johnson J (ed). WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany (15 Feb 2010).
  • Mason JC. Large vessel vasculitis. In Royal College of Physicians. Horizons in Medicine 21. 21:11-20. Friedland JS (ed). Royal College of Physicians London, London (2009). Author weblink.

Conferences

  • Nadkarni S; Hollywood J; Mason JC; Dasgupta B; Perretti M. Annexin-A1: A Potential Novel Biomarker in Giant Cell Arteritis. 63:S593-S593. (Oct 2011).
  • Mukherjee J; Youngstein T; Pyne D; Hughes E; Nash J; Andrews J; Mason JC. (18)FDG-PET-CT AND SYNTHETIC GRAFT UPTAKE IN LARGE VESSEL VASCULITIS. 50:147-147. (Apr 2011).
  • Sperone A; Birdsey GM; Dryden N; Madden LE; Evans P; Mason JC; Paleolog E; Haskard DO; et alRandi AM. The Transcription Factor Erg Represses ICAM-1 Expression and Vascular Inflammation. 30:E228-E228. (Nov 2010).
  • Sperone A; Dryden N; Birdsey GM; Madden LE; Evans P; Mason JC; Boyle J; Paleolog E; et alHaskard DO; Randi AM. The transcription factor Erg represses ICAM-1 expression and vascular inflammation. 213:E17-E17. (Nov 2010). DOI.
  • Zakkar M; van der Heiden K; Chaudhury H; Krams R; Haskard DO; Mason JC; Evans PC. ACTIVATION OF NF-E2 RELATED FACTOR-2 (NRF2) PROTECTS ARTERIES FROM EXHIBITING A PRO-INFLAMMATORY STATE. 95. (15 Nov 2009). DOI.
  • Sperone A; Birdsey GM; Dryden N; Evans P; Boyle J; Haskard DO; Mason JC; Randi AM. THE TRANSCRIPTION FACTOR ERG PREVENTS VASCULAR INFLAMMATION BY REPRESSING ICAM-1 EXPRESSION. 95. (15 Nov 2009). DOI.
  • Boyle JJ; Johns M; Mason JC; Haskard DO. MONOCYTE DIFFERENTIATION TO AN ATHEROPROTECTIVE PHENOTYPE EXPRESSING HEME OXYGENASE-1 PIVOTALLY REQUIRES A HEME-INDUCIBLE TRANS-ACTIVATING FACTOR AND IS COUNTERACTED BY THE NUCLEAR RECEPTOR REVERB. 95. (15 Nov 2009). DOI.
  • Recio-Mayoral A; Mason JC; Kaski JC; Rubens MB; Harari OA; Camici PG. Microvascular Dysfunction and Chronic Inflammation in Patients without Cardiovascular Risk Factors. 118:S1068-S1068. (28 Oct 2008).
  • Zakkar M; Chaudhury H; Krams R; Mason JC; Clark AR; Haskard DO; Evans PC. Map kinase phosphatase-1 suppresses endothelial activation in regions of the arterial tree that are resistant to atherosclerosis. Spring Meeting of the British-Atherosclerosis-Society on Angiogenesis and Atherosclerosis. 199:465-465. (Aug 2008).
  • Birdsey GM; Dryden NH; Arnsellem V; Gebhardt F; Haskard DO; Dejana E; Mason JC; Randi AM. The transcription factor Erg regulates angiogenesis and endothelial apoptosis through VE-cadherin. 199:465-465. (Aug 2008). DOI.
  • Keenan NG; Mason JC; Maceira A; Roughton M; Assomull R; O'Hanlon R; Andrews J; Gatehouse PD; et alFirmin DN; Haskard DO; Pennell DJ. Integrated cardiac and vascular assessment in Takayasu's arteritis and systemic lupus erythematosus by cardiovascular magnetic resonance. Annual Scientific Conference of the British-Cardiovascular-Society. 94:A78-A79. (Jul 2008).
  • Mason JC; Keenan N; Maceira A; Roughton M; Assomull R; O'Hanlon R; Andrews J; Firmin D; et alHaskard DO; Pennell DJ. Integrated cardiac and vascular assessment in Takayasu's arteritis and systemic lupus erythematosus using cardiovascular magnetic resonance. 47:II101-II101. (Apr 2008).
  • Hamdulay SS; Ali F; Ali N; Steinberg R; Lidington E; Haskard DO; Mason JC. Statins and rapamycin: Therapeutic synergy in vascular cytoprotection. Annual Meeting of the British-Society-of-Rheumatology. 46:I9-I9. (Apr 2007).
  • Steinberg R; Harari OA; Lidington E; Boyle J; Nohadani M; Ohba M; Samarel A; Haskard DO; et alMason JC. Protein kinase C (PKC)epsilon protects human vascular endothelial cells against apoptosis through induction of Bcl-2 and inhibition of caspase-3. Annual Meeting of the British-Society-of-Rheumatology. 46:I1-I1. (Apr 2007).
  • Florey O; Mason JC; Haskard DO. Anti-endothelial cell (EC) antibodies (AECA) found in SLE augment cytokine-mediated neutrophil-EC interactions under physiological flow: Cross-talk between FC gamma RIIA, G-protein coupled receptor signalling and LFA-1. Annual European Congress of Rheumatology (EULAR 2006). 65:103-104. (Jul 2006).
  • Steinberg R; Harari O; Lidington E; Samarel A; Ohba M; Haskard DO; Mason JC. Protein kinase C epsilon (PKC epsilon) regulates BCL-2 expression in vascular endothelial cells (EC) and protects against apoptosis. 14th International Vascular Biology Meeting. 45:192-192. (Sep 2006).
  • Partridge J; Enesa K; Kinderlerer A; Johns M; Mason JC; Haskard DO; Evans PC. Shear stress modulates endothelial responses to TNF alpha by suppressing proinflammatory transcripts and enhancing cytoprotective transcripts. Joint Autumn Meeting of the British-Society-for-Cardiovascular-Research/British-Atherosclerosis-Society. 93:U182-U182. (Feb 2007).
  • Hamdulay SS; Boyle JJ; Lefroy D; Nadra IJ; Mason JC. Hypocomplementaemic urticarial vasculitis complicated by severe valvular heart disease. BSR Annual Meeting/BHPR Spring Meeting. 45:I140-I140. (Apr 2006).
  • Kinderlerer AR; Steinberg RM; Lidington EA; Soares MP; Haskard DO; Mason JC. Heme-oxygenase-1 upregulation induces Decay-Accelerating Factor (DAF) on vascular endothelium and protects against complement-mediated injury. BSR Annual Meeting/BHPR Spring Meeting. 45:I31-I31. (Apr 2006).
  • Kinderlerer AR; Johns M; Lidington EA; Boyle JJ; Haskard DO; Mason JC. Laminar shear stress upregulates the complement-regulatory protein CD59: A novel cytoprotective mechanism against complement-mediated injury on EC. BSR Annual Meeting/BHPR Spring Meeting. 45:I28-I28. (Apr 2006).
  • Birdsey GM; Amsellem V; Mason JC; Gebhardt F; Taylor KM; Haskard DO; Randi AM. The transcription factor ERG regulates angiogenesis and apoptosis. 93. (Feb 2007).
  • Ng WF; Schiff R; Dockery F; Davies KA; Rajkumar C; Mason JC. Takayasu's arteritis is associated with reduced aortic compliance. 64:261-261. (Jul 2005).
Share this on DeliciousTweet thisDigg thisStumble thisShare this on Facebook